CD24 for Cardiovascular Researchers: A Key Molecule in Cardiac Immunology, Marker of Stem Cells and Target for Drug Development
The study of the membrane protein, CD24, and its emerging role in major disease processes, has made a huge leap forward in the past two decades. It appears to have various key roles in oncogenesis, tumor progression and metastasis, stem cell maintenance and immune modulation. First described in the...
Main Authors: | Eyal Sagiv, Michael A. Portman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/4/260 |
Similar Items
-
Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200
by: Sun Young Moon, et al.
Published: (2023-10-01) -
CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival
by: Noa Gross Even-Zohar, et al.
Published: (2022-05-01) -
Cardiogenic shock temporally associated with COVID-19 vaccination after prior COVID-19 infection: A case report
by: Elizabeth M. Jean-Marie, et al.
Published: (2022-01-01) -
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS
by: Ioannis Grigoropoulos, et al.
Published: (2024-04-01) -
VAERS Vasculitis Adverse Events Retrospective Study: Etiology Model of Immune Complexes Activating Fc Receptors in Kawasaki Disease and Multisystem Inflammatory Syndromes
by: Darrell O. Ricke, et al.
Published: (2024-03-01)